Atazanavir

Major

Atazanavir Acetaminophen And Codeine Capital® & Codeine Explained Increased codeine and morphine exposure Details Atazanavir Abametapir Explained Increased exposure of CYP3A4 substrate Details Atazanavir Omeprazole Gastrobim Explained Reduced atazanavir exposure, reduced efficacy of atazanavir and development of resistance Details Atazanavir Amitriptyline Elavil Explained Increased TCA exposure and an increased risk of QT interval prolongation Details Atazanavir Sertraline Explained An increased risk of QT interval prolongation Details Atazanavir Buprenorphine Belbuca Explained An increased risk of QT interval prolongation, increased buprenorphine exposure, an increased risk of buprenorphine-related advers... Details Atazanavir Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Atazanavir Acalabrutinib Calquence Increased acalabrutinib exposure and increased risk of toxicity Details Atazanavir Ado-Trastuzumab Emtansine Injection KADCYLA Increased exposure of cytotoxic component DM1 (maytansine derivative) and risk of toxicity Details Atazanavir Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Atazanavir Apixaban Eliquis Explained Increased apixaban exposure and an increased risk of bleeding Details Atazanavir Arsenic Trioxide Trisenox Increased risk of QT-interval prolongation and torsade de pointes Details Atazanavir Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Atazanavir Arsenic Trioxide Injection Trisenox Increased risk of QT-interval prolongation and torsade de pointes Details Atazanavir Asenapine Transdermal Patch Secuado An increased risk of QT interval prolongation Details Atazanavir Atogepant Qulipta Increased atogepant exposure Details Atazanavir Avapritinib Ayvakit Increased avapritinib exposure and an increased risk of the incidence and severity of adverse reactions Details Atazanavir Azithromycin AzaSite An increased risk of QT interval prolongation Details Atazanavir Betrixaban Bevyxxa® Increased betrixaban exposure and an increased risk of bleeding Details Atazanavir Atorvastatin Atorvaliq Increased risk of atorvastatin toxicity, including an increased risk of myopathy or rhabdomyolysis Details Atazanavir Cariprazine Vraylar Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Atazanavir Amlodipine Amvaz® Increased amLODIPine exposure and an increased risk of hypotension and edema Details Atazanavir Anagrelide Agrylin Increased risk of QT interval prolongation Details Atazanavir Avanafil Stendra Decreased avanafil clearance and increased avanafil plasma concentrations Details Atazanavir Axitinib Inlyta Increased axitinib plasma concentrations Details Atazanavir Bedaquiline Sirturo Increased bedaquiline exposure and an increased risk of QT interval prolongation Details Atazanavir Bosutinib Bosulif Increased bosutinib exposure Details Atazanavir Brentuximab Vedotin Injection Adcetris Increased exposure to active entity of brentuximab vedotin Details Atazanavir Brexpiprazole Rexulti Increased brexpiprazole exposure Details Atazanavir Brigatinib Alunbrig Increased brigatinib exposure Details Atazanavir Budesonide Entocort Increased budesonide exposure Details Atazanavir Budesonide Nasal Spray Rhinocort Increased budesonide exposure Details Atazanavir Budesonide Oral Inhalation Pulmicort Increased budesonide exposure Details Atazanavir Cabazitaxel Injection Jevtana Increased cabazitaxel exposure Details Atazanavir Cabotegravir Apretude Loss of virologic response and possible development of viral resistance Details Atazanavir Chloroquine Aralen® Increased risk of QT-interval prolongation Details Atazanavir Ciclesonide Nasal Spray Omnaris Increased corticosteroid exposure and an increased risk of corticosteroid-related adverse effects Details Atazanavir Ciclesonide Oral Inhalation Alvesco Increased corticosteroid exposure and an increased risk of corticosteroid-related adverse effects Details Atazanavir Clopidogrel Plavix Reduced clopidogrel (active metabolite) exposure and reduced efficacy of clopidogrel Details Atazanavir Cobimetinib Cotellic Increased cobimetinib plasma concentrations Details